Groetzinger, L. M., Miller, T. J., Rivosecchi, R. M., Smith, R. E., Gladwin, M. T., & Rivera-Lebron, B. N. (2018). Apixaban or Rivaroxaban Versus Warfarin for Treatment of Submassive Pulmonary Embolism After Catheter-Directed Thrombolysis. Clin Appl Thromb Hemost.
Citação norma ChicagoGroetzinger, Lara M., Taylor J. Miller, Ryan M. Rivosecchi, Roy E. Smith, Mark T. Gladwin, and Belinda N. Rivera-Lebron. "Apixaban or Rivaroxaban Versus Warfarin for Treatment of Submassive Pulmonary Embolism After Catheter-Directed Thrombolysis." Clin Appl Thromb Hemost 2018.
Citação norma MLAGroetzinger, Lara M., et al. "Apixaban or Rivaroxaban Versus Warfarin for Treatment of Submassive Pulmonary Embolism After Catheter-Directed Thrombolysis." Clin Appl Thromb Hemost 2018.